The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. (GSMS) to supply 11,462 bottles of Tenofovir Disoproxil Fumarate 300mg tablets annually. The contract is for a base year with four one-year option periods, with a potential total value of $1,144,480.70. GSMS, a for-profit pharmaceutical manufacturer and distributor, will provide the tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) through the VA and DoD Pharmaceutical Prime Vendor Programs. The contract was awarded on April 27, 2024, and orders may be placed through May 7, 2024. There was no set-aside used for this procurement, which was issued under NAICS code 325412 - Pharmaceutical Preparation Manufacturing. The solicitation was posted on SAM.gov on October 6, 2023, with responses due by November 2, 2023.
This Indefinite Delivery Contract supports the VA, DoD, BOP, and IHS's requirements for Tenofovir Disoproxil Fumarate 300mg tablets, a medication used to treat HIV and hepatitis B. By utilizing an IDV, the agencies can order the product on an as-needed basis to meet patient care needs across VA medical centers, military treatment facilities, prisons, and IHS sites nationwide. This award allows GSMS, a proven pharmaceutical supplier to these federal agencies, to provide a continuous, uninterrupted source of the critical drug.
Generated 5/8/24, 9:21 AM